New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
Rare oral cancer has distinct genetic profile
$120m investment to grow talent and innovation in Virginia
Potential of enzymatic single-stranded DNA for non-viral gene editing
The next era of CGT
FDA approves PADCEV plus Keytruda for certain patients with bladder cancer
‘Groundbreaking’ rapid diagnostic test for prostate cancer
Breakthrough in cancer immunotherapy using marine bacteria
Trial results could shorten TB treatment time
Customised cells to fight brain cancer